Shuichiro Neshige

Long-term safety and efficacy of patisiran for hereditary transthyretin-mediated amyloidosis with polyneuropathy: 12-month results of an open-label extension study

David Adams, Michael Polydefkis, Alejandra González‐Duarte et al. · The Lancet Neurology · 2020 · 154 citations · Full text

Alzheimer's Disease, Open-label Extension Study, Medicine +5

Low-dose perampanel improves refractory cortical myoclonus by the dispersed and suppressed paroxysmal depolarization shifts in the sensorimotor cortex

Kazuki Oi, Shuichiro Neshige, Takefumi Hitomi et al. · Clinical Neurophysiology · 2019 · 52 citations

Neural Mechanism, Neurophysiology, Neuroanatomy +11

Seizures after intracerebral hemorrhage; risk factor, recurrence, efficacy of antiepileptic drug

Shuichiro Neshige, Masaru Kuriyama, Takeshi Yoshimoto et al. · Journal of the Neurological Sciences · 2015 · 45 citations

Thrombosis, Ischemic Stroke, Antiepileptic Drug +12

Ischemic Stroke Mortality Is More Strongly Associated with Anemia on Admission Than with Underweight Status

Satoshi Kubo, Naohisa Hosomi, Naoyuki Hara et al. · Journal of Stroke and Cerebrovascular Diseases · 2017 · 21 citations · Full text

Cerebrovascular Disease, Obesity, Metabolic Syndrome +17

Barriers to telemedicine among physicians in epilepsy care during the COVID-19 pandemic: A national-level cross-sectional survey in Japan

Takafumi Kubota, Naoto Kuroda, Toru Horinouchi et al. · Epilepsy & Behavior · 2021 · 19 citations · Full text

Primary Care, Connected Health, Health Policy +13